Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02347371
Other study ID # VSZR - 001
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 2015
Est. completion date May 2020

Study information

Verified date April 2021
Source Semmelweis University Heart and Vascular Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The purpose of this registry is to determine the long term outcomes of heart transplantations performed at the Semmelweis University Heart and Vascular Center. All eventual interventional and non-interventional procedures will be accounted for and summarized.


Recruitment information / eligibility

Status Completed
Enrollment 11
Est. completion date May 2020
Est. primary completion date May 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Heart transplant recipient - >18 years old - Signed informed consent - Cared for at the Semmelweis University Heart and Vascular Center Exclusion Criteria: - Denies consent to registry

Study Design


Related Conditions & MeSH terms

  • Disorder Related to Cardiac Transplantation

Locations

Country Name City State
Hungary Semmelweis University Heart and Vascular Center Budapest

Sponsors (1)

Lead Sponsor Collaborator
Semmelweis University Heart and Vascular Center

Country where clinical trial is conducted

Hungary, 

Outcome

Type Measure Description Time frame Safety issue
Primary Outcome of heart transplantation as measured by all-cause mortality All-cause mortality will be assessed after transplantation in all participating subjects. 5 years
Secondary Morbidity after heart transplantation All invasive procedures that are required after initial surgery will be tracked and accounted for. 5 years
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02503566 - Assessment of Cardiac Allograft Vasculopathy by Optical Coherence Tomography N/A
Completed NCT00377962 - Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation Phase 4